Light Therapy for Alzheimer's Disease
Trial Summary
What is the purpose of this trial?
This trial uses special blue and red lights that either flicker regularly or randomly. It aims to see how these lights affect sleep and cognitive functions in general participants. Blue light helps regulate the body clock, and the flickering might have additional effects.
Do I have to stop my current medications for this trial?
The trial protocol does not specify if you need to stop taking your current medications. However, if you are taking sleep medication, you cannot participate in the trial.
What data supports the idea that Light Therapy for Alzheimer's Disease is an effective treatment?
The available research shows that Light Therapy can be effective for people with Alzheimer's Disease. For example, using a self-luminous light table increased sleep quality and reduced agitation and depression. Another study found that tailored lighting improved sleep, mood, and behavior in people with Alzheimer's. However, one study using light visors did not find consistent improvements, possibly due to issues like the timing or method of light delivery. Overall, Light Therapy seems promising, especially when the light is delivered in a way that aligns with the body's natural rhythms.12345
What safety data exists for light therapy in Alzheimer's treatment?
The safety data for light therapy in Alzheimer's treatment is limited and varies across studies. A pilot study using light visors found no consistent biological effects, possibly due to insufficient light exposure or advanced stages of Alzheimer's. Another study highlighted the potential of light therapy to regulate sleep-wake patterns in dementia patients, but methodological issues were noted. A review of light therapy studies indicated poor methodological quality, suggesting the need for better lighting descriptions and involvement of light specialists. Overall, while light therapy is established for other conditions like Seasonal Affective Disorder, its safety and efficacy in Alzheimer's require further investigation.35678
Eligibility Criteria
This trial is for people living at home or in assisted living with mild Alzheimer's or cognitive impairment, who have sleep issues but aren't on sleep meds. They can't join if they have severe eye problems, live in nursing care, or have certain neurological conditions.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Baseline
Participants undergo a baseline week before starting the assigned lighting condition
Treatment
Participants experience their assigned lighting condition for two hours in the morning for 8 weeks
Washout
A 4-week washout period where no treatment is administered
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Rhythmic Light Therapy (Behavioural Intervention)